Simptomele long-COVID la pacienţii pediatrici cu boală cronică renală în stadiu terminal: un studiu descriptiv, transversal, realizat într-un singur centru DOI

Irina Bulată-Pop,

Andreea-Liana Boț,

Bogdan Bulată

et al.

Pediatru ro, Journal Year: 2024, Volume and Issue: 3(75), P. 22 - 22

Published: Jan. 1, 2024

Long COVID: Long-Term Impact of SARS-CoV2 DOI Creative Commons

Huda Makhluf,

Henry Madany,

Kenneth Kim

et al.

Diagnostics, Journal Year: 2024, Volume and Issue: 14(7), P. 711 - 711

Published: March 28, 2024

Four years post-pandemic, SARS-CoV-2 continues to affect many lives across the globe. An estimated 65 million people suffer from long COVID, a term used encapsulate post-acute sequelae of infections that multiple organ systems. Known symptoms include chronic fatigue syndrome, brain fog, cardiovascular issues, autoimmunity, dysautonomia, and clotting due inflammation. Herein, we review COVID symptoms, proposed theories behind pathology, diagnostics, treatments, clinical trials underway explore treatments for viral persistence, autonomic cognitive dysfunctions, sleep disturbances, fatigue, exercise intolerance.

Language: Английский

Citations

11

The compositional and functional imbalance of the gut microbiota in CKD linked to disease patterns DOI Creative Commons
Jing Li, Yang Shen,

Kaixin Yan

et al.

Journal of Translational Medicine, Journal Year: 2024, Volume and Issue: 22(1)

Published: Aug. 16, 2024

The prevalence of chronic kidney disease (CKD) is on the rise, posing a significant public health challenge. Although gut microbiome dysbiosis has been implicated in impairment functions, existence pathological subtypes-linked differences remains largely unknown. We aimed to characterize intestinal microbiota patients with membranous nephropathy (MN), IgA (IgAN), minimal change (MCD), and ischemic renal injury (IRI) order investigate intricate relationship between CKD across different subtypes. conducted cross-sectional study involving 94 various patterns 54 healthy controls (HCs). clinical parameters were collected, stool samples obtained from each participant. Gut microbial features analyzed using 16S rRNA sequencing taxon annotation compare HC, CKD, MN, IgAN, MCD, IRI groups. subjects exhibited significantly reduced alpha diversity, modified community structures, disrupted composition potential functions compared control group. opportunistic pathogen Klebsiella enrichment whereas Akkermansia showed higher abundance HCs. further revealed presence heterogeneity signatures diverse types, including IRI. depression family Lachnospiraceae genus Bilophila was prominently observed exclusively while suppressed Streptococcus detected only individuals remarkable expansion Escherichia uniquely found cases also encompassed development classifiers employing diagnostic markers accurately discriminate distinct subtypes CKD. dysregulation strongly correlated exhibiting specificity towards patterns. Our emphasizes significance considering when assessing impact development, diagnosis, treatment

Language: Английский

Citations

4

Anti‐SARS‐CoV‐2 Antibodies in Long‐COVID—Markers of Protection or Elevated Risk? A Systematic Review DOI Open Access
Sylvia Mink,

F.X. Wilhelm,

Janne Cadamuro

et al.

Reviews in Medical Virology, Journal Year: 2025, Volume and Issue: 35(2)

Published: Feb. 24, 2025

Long-COVID affects a significant number of COVID-19 survivors, profoundly impacting daily life and work. Although research suggests potential link between antibody levels long-COVID risk, findings remain inconclusive. Understanding dynamics could support the identification patients at improve diagnosis, guide protective strategies such as vaccination. Despite growing evidence, no systematic review has yet evaluated current literature on this topic. We therefore aimed to synthesise evaluate existing evidence association anti-SARS-CoV-2 titres long-COVID, with goal clarifying their role in predicting guiding patient management, informing future directions. Studies published PubMed/Medline databases January 2020 October 2024 were included without language restrictions. body fluids other than serum/blood excluded. Study selection quality assessment was conducted independently by two researchers. After screening 949 studies, 58 studies encompassing 53,739 individuals, 7812 patients, included. Evidence highly heterogenous but most reported an anti-SARS-CoV-2-spike antibodies although nature appeared be dependent time from acute infection. Low during associated increased risk long-COVID. The low that maintaining sufficiently high may protective. However, level is further sufficient power are required confirm potentially determine cutoffs.

Language: Английский

Citations

0

A Comprehensive Review of the Global Epidemiology, Clinical Management, Socio-Economic Impacts, and National Responses to Long COVID with Future Research Directions DOI Creative Commons

Xiufang Song,

Weiwei Song, Lizhen Cui

et al.

Diagnostics, Journal Year: 2024, Volume and Issue: 14(11), P. 1168 - 1168

Published: May 31, 2024

Long COVID, characterized by a persistent symptom spectrum following SARS-CoV-2 infection, poses significant health, social, and economic challenges. This review aims to consolidate knowledge on its epidemiology, clinical features, underlying mechanisms guide global responses;

Language: Английский

Citations

3

The Role of Dental-derived Stem Cell-based Therapy and Their Derived Extracellular Vesicles in Post-COVID-19 Syndrome-induced Tissue Damage DOI
Mitra Rostami,

Pouria Farahani,

Samar Esmaelian

et al.

Stem Cell Reviews and Reports, Journal Year: 2024, Volume and Issue: 20(8), P. 2062 - 2103

Published: Aug. 16, 2024

Language: Английский

Citations

3

A Comprehensive Global Review of Epidemiology, Clinical Management, Socio-Economic Impacts and National Responses of Long COVID with Future Research Directions DOI Open Access

Xiufang Song,

Weiwei Song, Lizhen Cui

et al.

Published: April 26, 2024

Background: Long COVID, characterized by a persistent symptom spectrum following SARS-CoV-2 infection, poses significant health, social, and economic challenges. This review aims to consolidate knowledge on its epidemiology, clinical features, underlying mechanisms guide global responses; Methods: We conducted systematic literature review, analyzing peer-reviewed articles reports gather comprehensive data long COVID’s symptomatology, management approaches; Results: Our analysis revealed wide array of COVID symptoms risk factors, with notable demographic variability. The current understanding pathophysiology suggests multifactorial origin yet remains partially understood. Emerging diagnostic criteria potential therapeutic strategies were identified, highlighting advancements in management.; Conclusion: highlights the multifaceted nature revealing broad symptoms, diverse complex interplay physiological underpinning condition. disorders will continue weigh healthcare systems years come. Ad-dressing requires holistic strategy that integrates care, social support, policy initiatives. findings underscore need for increased international cooperation research health planning address challenges COVID. There is call continued refinement treatment modalities, emphasizing multidisciplinary approach manage ongoing evolving impacts

Language: Английский

Citations

2

COVID-19 vaccination among adolescents and young adults with chronic kidney conditions: a single-center experience DOI
Demet Baltu, Eda Didem Kurt Şükür, Tuğba Öztürk

et al.

Klinische Pädiatrie, Journal Year: 2024, Volume and Issue: unknown

Published: May 31, 2024

Abstract Background Following the pandemic of COVID-19, main focus has been on COVID-19 vaccines and herd immunity. Although safety shown in clinical trials, children with chronic diseases were not included. We investigated side effect profile adolescents kidney disease. Methods A questionnaire including demographic information, history vaccination status, vaccine-related effects was administered to patients disease (CKD) stage 2–5, glomerular treated immunosuppression, transplant recipients. Results Ninety-eight vaccinated CoronaVac-inactivated SARS-CoV-2 (n=16) or BNT162b2 messenger RNA (mRNA) COVİD-19 (n=82) vaccine. The mean age 16.90±2.36 years. most common local pain, fatigue, fever. No serious renal flare observed. There no significant difference reported after mRNA-RNA as compared Corona Vac-inactivated relationship found between frequency according age, filtration rate, immunosuppressive treatments, CKD stage, underlying Conclusion data are subjective because they obtained through a studies long-term follow-up needed, our early experience suggests that vaccine is safe young adults should be encouraged vaccinated.

Language: Английский

Citations

0

Смертність у хворих на ХХН VГД з постковідним синдромом: багатоцентрове, проспективне, когортне дослідження DOI Creative Commons

М. Kolesnyk,

N. Stepanova,

Tetyana Ostapenko

et al.

Ukrainian Journal of Nephrology and Dialysis, Journal Year: 2024, Volume and Issue: 3(83), P. 68 - 78

Published: Aug. 3, 2024

Термінальна стадія хронічної хвороби нирок, яка потребує лікування методом гемодіалізу (ХХН VГД), є критичною глобальною проблемою охорони здоров'я, ще більше ускладнилась пандемією COVID-19. Хоча відомо, що постковідний синдром (ПКС) погіршує якість життя ГД пацієнтів, його вплив на смертність залишається маловивченим. Метою цього дослідження було проаналізувати хворих ХХН VГД з ПКС та визначити її клінічні лабораторні детермінанти. Методи. Це багатоцентрове, проспективне включало пацієнтів чотирьох діалізних центрів України, які перенесли COVID-19 станом кінець березня 2022 року. Зібрані дані включали демографічні, параметри і наявність ПКС. Основними кінцевими точками були у хворих, асоційована або без нього. Результати. З 465 353 відповідали критеріям включення. був діагностований 222 (62,9%), який асоціювався чоловічою статтю, старшим віком, діабетом, тимчасовим судинним доступом, вищим індексом Чарлсона, нижчими показниками Kt/V, гемоглобіну альбуміну, вищими балами CONUT підвищеними рівнями СРБ. Протягом двох років спостереження зареєстровано 38 (11,4%) летальних випадків; основними причинами смерті серцево-судинні події (42,2%) інфекційні ускладнення (21,1%). Багатофакторний регресійний аналіз Кокса визначив, старший вік (OR 1,32, 95% CI 1,03; 1,66), тривалість діалізу 1,86, 1,77; 1,97), діабет 3,57, 1,81; 7,06), вища коморбідність 4,22, 2,11; 7,82), гірший нутритивний статус 1,66, 1,08; 12,3), тимчасовий судинний доступ 1,88, 1,16; 3,86), високий артеріальний тиск 1,37, 1,82) рівень С-реактивного білка 1,68, 1,49; 1,95) тяжкий перебіг COVID-19, вимагав госпіталізації 5,7, 3,73; 7,89), незалежними предикторами смертності. У той же час, цільові рівні 0,87, 0,66; 0,99) Kt/V 0,74, 0,68; 0,96), а також вакцинація проти 0,17, 0,05; 0,61) статистично значущо знижували імовірність смерті. Наявність не впливала виживаність протягом років. Висновки. Дворічна визначається комбінацією демографічних клініко-лабораторних факторів, таких як вік, тривале ГД, коморбідна патологія, білково-енергетична недостатність, доступ, неадекватна діалізна доза, низькй гемоглобіну, хронічне запалення, недосягнення цільового рівня артеріального тиску, негативний вакцинальний гострого періоду необхідністю кисневої підтримки. Вакцинація підтримання цільових рівнів показників моніторингу після мають вирішальне значення для покращення виживання цієї категорії хворих.

Citations

0

Deciphering the pathogen heterogeneity for precise diagnosis and personalized therapeutics of infections after kidney transplantation: insights from metagenomic next-generation sequencing DOI Creative Commons
Xin Ye, Yuxin Lin,

Jiangnan Yang

et al.

Frontiers in Cellular and Infection Microbiology, Journal Year: 2024, Volume and Issue: 14

Published: Nov. 14, 2024

Introduction The aim of this study was to compare the detection performance mNGS against that conventional tests (CT) in patients suffering from infection after kidney transplantation. Methods A total 138 samples 85 transplant with acute or chronic infections were simultaneously analyzed using and CT July 2021 August 2023. Results Compared CT, demonstrated a higher sensitivity (95.96% vs. 27.27%) but lower specificity (48.72% 84.62%) pathogen detection. Moreover, exhibited significant advantages detecting mixed rare infections. pathogens commonly identified severe respiratory syndrome coronavirus 2 (SARS-CoV-2), followed by Pneumocystis jirovecii Cytomegalovirus (CMV). guided precise clinical diagnosis 89.13% cases assisted altering therapeutics empirical antibiotic approaches personalized plans 56.10% cases, including treatment escalation (40.65%), initiation (11.38%), drug adjustment (3.25%), de-escalation (0.81%). Discussion Our superior its value. This reflected great potential as complementary technology for patients.

Language: Английский

Citations

0

Simptomele long-COVID la pacienţii pediatrici cu boală cronică renală în stadiu terminal: un studiu descriptiv, transversal, realizat într-un singur centru DOI

Irina Bulată-Pop,

Andreea-Liana Boț,

Bogdan Bulată

et al.

Pediatru ro, Journal Year: 2024, Volume and Issue: 3(75), P. 22 - 22

Published: Jan. 1, 2024

Citations

0